Making it easier for the patient in the evolving environment of COVID-19

Reducing patient burden has never been so important as we navigate through a global healthcare crisis.  Making it convenient for the patient to continue assessments and stay engaged in the trial will support the patient and help you to keep your trial on track.

Specialised In-Home Clinical Services delivered by Symphony Clinical Research (Acquired by ICON in 2019) can be provided in all phases and a wide range of therapeutic areas.

Some of the benefits include:

  • Increased patient retention – patients are less likely to drop-out as participating is so much easier for them
  • Improved compliance – with more individual attention, support and oversight, patients are more likely to remain compliant with their trial regimen  
  • Enhanced patient enrollment – patients will consider participation because of the option to interact with study staff either at home or in more convenient locations   

Symphony Clinical Research has successfully deployed these services for a range of clinical trials and has a comprehensive network throughout the world.  

Webinar: In-home visits to reduce patient burden and improve retention in clinical trials

Webinar: In-home visits to reduce patient burden

The FDA guidance on clinical trials during COVID-19 advised sponsors to evaluate alternative methods for safety assessments to protect patients, where necessary and feasible.

Watch the webinar recording

Solutions are tailored to specific study requirements, patient populations and include the following options:

  • Study drug administration (infusion, inhaled, injection, topical, oral)
  • Blood collection or local and central laboratory processing (PK, PD, safety labs)
  • Biological sample collection
  • Vital signs, weight and height
  • ECG
  • Training, coaching, and education for patients (self­administration)
  • Timely communication for Site safety and reporting
  • Patient questionnaires and diaries
  • Device education and management
  • Medical waste disposal
  • ICH/GCP, data security and privacy, dangerous goods and other regulatory compliance

Contact us  today to find out how reducing burden in clinical trials can improve predictability in clinical trials.